Log in | Register
Diamantis I. Tsilimigras MD, Rittal Mehta MPH, Dimitrios Moris MD, PhD, Kota Sahara MD, Fabio Bagante MD, Anghela Z. Paredes MD, MS, Ayesha Farooq MD, Francesca Ratti MD, Hugo P. Marques MD, Silvia Silva MD, Olivier Soubrane MD, Vincent Lam MD, George A. Poultsides MD, Irinel Popescu MD, Razvan Grigorie MD, PhD, Sorin Alexandrescu MD, Guillaume Martel MD, Aklile Workneh MD, Alfredo Guglielmi MD, T Hepatobiliary Tumors Online First ™ - November , 2019
View full article HTML | View full article PDF | Download Citation
There is an ongoing debate about expanding the resection criteria for hepatocellular carcinoma (HCC) beyond the Barcelona Clinic Liver Cancer (BCLC) guidelines. We sought to determine the factors that held the most prognostic weight in the pre- and postoperative setting for each BCLC stage by applying a machine learning method.
Patients who underwent resection for BCLC-0, A and B HCC between 2000 and 2017 were identified from an international multi-institutional database. A Classification and Regression Tree (CART) model was used to generate homogeneous groups of patients relative to overall survival (OS) based on pre- and postoperative factors.
Among 976 patients, 63 (6.5%) had BCLC-0, 745 (76.3%) had BCLC-A, and 168 (17.2%) had BCLC-B HCC. Five-year OS among BCLC-0/A and BCLC-B patients was 64.2% versus 50.2%, respectively (p = 0.011). The preoperative CART model selected α-fetoprotein (AFP) and Charlson comorbidity score (CCS) as the first and second most important preoperative factors of OS among BCLC-0/A patients, whereas radiologic tumor burden score (TBS) was the best predictor of OS among BCLC-B patients. The postoperative CART model revealed lymphovascular invasion as the best postoperative predictor of OS among BCLC-0/A patients, whereas TBS remained the best predictor of long-term outcomes among BCLC-B patients in the postoperative setting. On multivariable analysis, pathologic TBS independently predicted worse OS among BCLC-0/A (hazard ratio [HR] 1.04, 95% confidence interval [CI] 1.02–1.07) and BCLC-B patients (HR 1.13, 95% CI 1.06–1.19) undergoing resection.
Prognostic stratification of patients undergoing resection for HCC within and beyond the BCLC resection criteria should include assessment of AFP and comorbidities for BCLC-0/A patients, as well as tumor burden for BCLC-B patients.
Go to Issue Contents
Add this article to your Personal Archive
ANNALS ON SOCIAL MEDIA
@AnnSurgOncol
Join the conversation!
Follow the journal on Twitter and Facebook.
Help to expand the reach of the journal to support the research and practice needs of surgical oncologists and their patients.